Loading...
Corrigendum to"adjuvant immunotherapy in the modern management of resectable melanoma: current status and outlook to 2028": [ESMO Open 10 (2025) 104295]
Donia, M. Jespersen, H. Jalving, M. Lee, R. Eriksson, H. Hoeller, C. Hernberg, M. Gavrilova, I. Kandolf, L. Liszkay, G.
Donia, M.
Jespersen, H.
Jalving, M.
Lee, R.
Eriksson, H.
Hoeller, C.
Hernberg, M.
Gavrilova, I.
Kandolf, L.
Liszkay, G.
Abstract
Authors
Donia, M.
Jespersen, H.
Jalving, M.
Lee, R.
Eriksson, H.
Hoeller, C.
Hernberg, M.
Gavrilova, I.
Kandolf, L.
Liszkay, G.
Helgadottir, H.
Zhukavets, A.
Pjanova, D.
Marquez-Rodas, I.
Neyns, B.
Westgeest, H.
Pourmir, I.
Sobczuk, P.
Ellebaek, E.
Amaral, T.
Jespersen, H.
Jalving, M.
Lee, R.
Eriksson, H.
Hoeller, C.
Hernberg, M.
Gavrilova, I.
Kandolf, L.
Liszkay, G.
Helgadottir, H.
Zhukavets, A.
Pjanova, D.
Marquez-Rodas, I.
Neyns, B.
Westgeest, H.
Pourmir, I.
Sobczuk, P.
Ellebaek, E.
Amaral, T.
Affiliation
The Christie NHS Foundation Trust, Manchester, United Kingdom.
Description
Date
2026
Publisher
Collections
Files
Loading...
Found from Unpaywall
Adobe PDF, 149.5 KB
Keywords
Type
Article
Citation
Donia M, Jespersen H, Jalving M, Lee R, Eriksson H, Hoeller C, et al. Corrigendum to "adjuvant immunotherapy in the modern management of resectable melanoma: current status and outlook to 2028": [ESMO Open 10 (2025) 104295]. ESMO Open. 2026 Jan;11(1):105492. Epub 2026/01/04.